We have produced antipodoplanin (PDPN) cancer-specific mAbs (CasMabs), clone LpMab-2(8,9) and LpMab-23,(10,11) which specifically recognize cancer-type PDPN in tumor tissues. Here, PDPN is linked to neoplasm.